Avantor® Expands Life Sciences Innovation Center to Address Bioprocessing Needs in Protein Science, Monoclonal Antibodies (mAbs), Cell and Gene TherapyPRNewsWire • 06/30/20
Avantor® Announces Closing of Secondary Offering and Full Exercise of Underwriters' Option to Purchase Additional SharesPRNewsWire • 05/26/20
Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 04/30/20
Avantor: Punished Enough - Time To Buy A Misunderstood Healthcare Name - Behind The IdeaSeeking Alpha • 03/26/20
Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/07/20
U.S. IPO Week Ahead: Just One Biotech Is On The Calendar In A Slow Week For The IPO MarketSeeking Alpha • 11/09/19
Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/08/19
Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/12/19